Brasília – The proposal to establish a single agency for health technology assessment (HTA/ATS) lacks consensus, despite intense debate during the 9th ISPOR Brazil Congress.

Proponents argue that centralizing HTA evaluations could streamline decision-making and reduce duplication between CMED, Conitec and other regulatory bodies. Critics, however, caution that the concept is still underdefined, highlighting concerns about governance, funding independence, and structural complexity.

During the event, key topics included governance and transparency reforms, use of real-world data, artificial intelligence to speed assessments, and potential integration across the public and private sectors. Government representatives stated that discussion must evolve beyond academic debate toward political and regulatory alignment.

Source: Futuro da Saúde

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com